Implementation of antiretroviral therapy for life in pregnant/breastfeeding HIV+ women (Option B+) alongside rollout and changing guidelines for ART initiation in rural Zimbabwe: the Lablite Project experience

BACKGROUND: Life-long ART for pregnant and breastfeeding women (Option B+) was rolled-out in Zimbabwe from 2014 with simultaneous raising of the CD4 treatment-threshold in non-pregnant/breastfeeding adults and children >5 years to 500 cells/mm(3). METHODS: Lablite is an implementation project in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ford, Deborah, Muzambi, Margaret, Nkhata, Misheck J, Abongomera, George, Joseph, Sarah, Ndlovu, Makosonke, Mabugu, Travor, Grundy, Caroline, Chan, Adrienne K, Cataldo, Fabian, Kityo, Cissy, Seeley, Janet, Katabira, Elly, Gilks, Charles F, Reid, Andrew, Hakim, James, Gibb, Diana M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751886/
https://www.ncbi.nlm.nih.gov/pubmed/27984555
http://dx.doi.org/10.1097/QAI.0000000000001267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751886/
https://www.ncbi.nlm.nih.gov/pubmed/27984555
http://dx.doi.org/10.1097/QAI.0000000000001267

Ejemplares similares